ATE422880T1 - Heterofunktionelle copolymere von glycerol und polyethylenglykol, ihre konjugate und zusammensetzungen - Google Patents

Heterofunktionelle copolymere von glycerol und polyethylenglykol, ihre konjugate und zusammensetzungen

Info

Publication number
ATE422880T1
ATE422880T1 AT04809612T AT04809612T ATE422880T1 AT E422880 T1 ATE422880 T1 AT E422880T1 AT 04809612 T AT04809612 T AT 04809612T AT 04809612 T AT04809612 T AT 04809612T AT E422880 T1 ATE422880 T1 AT E422880T1
Authority
AT
Austria
Prior art keywords
conjugates
glycerol
polyethylene glycol
compositions
heterofunctional
Prior art date
Application number
AT04809612T
Other languages
English (en)
Inventor
Francis Ignatious
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Application granted granted Critical
Publication of ATE422880T1 publication Critical patent/ATE422880T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/04Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers only
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/08Preparation of carboxylic acid esters by reacting carboxylic acids or symmetrical anhydrides with the hydroxy or O-metal group of organic compounds
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/04Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers only
    • C08G65/06Cyclic ethers having no atoms other than carbon and hydrogen outside the ring
    • C08G65/08Saturated oxiranes
    • C08G65/10Saturated oxiranes characterised by the catalysts used
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/26Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers and other compounds
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/34Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from hydroxy compounds or their metallic derivatives
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/34Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from hydroxy compounds or their metallic derivatives
    • C08G65/48Polymers modified by chemical after-treatment
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/88Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
AT04809612T 2003-08-26 2004-08-25 Heterofunktionelle copolymere von glycerol und polyethylenglykol, ihre konjugate und zusammensetzungen ATE422880T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US49780203P 2003-08-26 2003-08-26

Publications (1)

Publication Number Publication Date
ATE422880T1 true ATE422880T1 (de) 2009-03-15

Family

ID=34465064

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04809612T ATE422880T1 (de) 2003-08-26 2004-08-25 Heterofunktionelle copolymere von glycerol und polyethylenglykol, ihre konjugate und zusammensetzungen

Country Status (7)

Country Link
US (1) US7196145B2 (de)
EP (1) EP1663171B9 (de)
JP (1) JP2007503514A (de)
AT (1) ATE422880T1 (de)
DE (1) DE602004019546D1 (de)
ES (1) ES2321841T3 (de)
WO (1) WO2005037911A2 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8017804B2 (en) 2004-05-05 2011-09-13 Silence Therapeutics Ag Lipids, lipid complexes and use thereof
HUE048419T2 (hu) 2004-12-22 2020-08-28 Nitto Denko Corp Gyógyszerhordozó és kit gyógyszerhordozó kit fibrózis gátlására
US20120269886A1 (en) 2004-12-22 2012-10-25 Nitto Denko Corporation Therapeutic agent for pulmonary fibrosis
ES2548515T3 (es) 2004-12-27 2015-10-19 Silence Therapeutics Gmbh Complejos lipídicos recubiertos con PEG y su uso
EP1878766B1 (de) * 2005-05-02 2020-01-01 The University of Tokyo Polymervesikel vom typ elektrostatische bindung
CA2653541C (en) 2005-06-06 2014-12-23 The University Of British Columbia Polymer-based serum albumin substitute
US9572886B2 (en) 2005-12-22 2017-02-21 Nitto Denko Corporation Agent for treating myelofibrosis
KR101670085B1 (ko) * 2006-07-21 2016-10-28 사일런스 테라퓨틱스 게엠베하 단백질 키나아제 3의 발현을 억제하기 위한 수단
JP2010509401A (ja) * 2006-11-14 2010-03-25 ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア アンチセンスオリゴヌクレオチドの効率的な核への送達
JP5515224B2 (ja) * 2007-02-28 2014-06-11 日油株式会社 多分岐鎖ポリオキシアルキレン誘導体
TWI407971B (zh) 2007-03-30 2013-09-11 Nitto Denko Corp Cancer cells and tumor-related fibroblasts
US8506993B2 (en) * 2007-08-14 2013-08-13 University Of Houston Compositions and methods for making and using multifunctional polymerized liposomes
EP2207570A2 (de) * 2007-09-14 2010-07-21 Nitto Denko Corporation Arzneimittelträger
US20110281934A1 (en) * 2008-11-06 2011-11-17 Phaserx, Inc. Micelles of hydrophilically shielded membrane-destabilizing copolymers
WO2010095052A2 (en) * 2009-02-21 2010-08-26 Sofradim Production Compounds and medical devices activated with solvophobic linkers
JP5502349B2 (ja) * 2009-03-13 2014-05-28 出光興産株式会社 水系潤滑剤
CN102573925B (zh) * 2009-10-05 2015-08-05 佳能株式会社 光声成像用造影剂和使用所述光声成像用造影剂的光声成像方法
US8359883B2 (en) * 2009-11-13 2013-01-29 Hasmukh Dholakiya Gemstone setting
DE102009059104A1 (de) * 2009-12-18 2011-06-22 Johannes-Gutenberg-Universität Mainz, 55122 Funktionelle verzweigte Polyether Copolymere sowie Verfahren zu ihrer Herstellung
WO2011106877A1 (en) 2010-03-01 2011-09-09 The University Of British Columbia Derivatized hyperbranched polyglycerols
JP5949037B2 (ja) 2011-03-30 2016-07-06 日油株式会社 末端に複数の水酸基を有するポリオキシエチレン誘導体
KR101483786B1 (ko) * 2011-05-27 2015-01-21 한국과학기술원 가지형 폴리에틸렌글리콜을 이용한 초자성나노입자의 용매 치환 방법 및 그 제조물
WO2014093343A2 (en) * 2012-12-10 2014-06-19 Massachusetts Institute Of Technology Multistage nanoparticle drug delivery system for the treatment of solid tumors
WO2016097358A1 (en) * 2014-12-18 2016-06-23 Universite de Bordeaux Polymer particles and biomaterials comprising the same
US10927250B2 (en) 2015-01-28 2021-02-23 Administrators Of The Tulane Educational Fund Nanoparticle polymer grafted dispersants and unimolecular micelles and methods of use
KR101607849B1 (ko) 2015-11-10 2016-03-31 영남대학교 산학협력단 생분해성 고분자 필름 및 그 제조방법
CN109562067A (zh) * 2016-08-02 2019-04-02 库里尔克思股份有限公司 制备脂质体的方法
DE102016119102A1 (de) * 2016-10-07 2018-04-12 Forschungszentrum Jülich GmbH Translokation von synthetischen Polymeren durch Lipidmembrane

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5077056A (en) 1984-08-08 1991-12-31 The Liposome Company, Inc. Encapsulation of antineoplastic agents in liposomes
US4762915A (en) 1985-01-18 1988-08-09 Liposome Technology, Inc. Protein-liposome conjugates
US4737323A (en) 1986-02-13 1988-04-12 Liposome Technology, Inc. Liposome extrusion method
US5013556A (en) 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
JP2593032B2 (ja) * 1992-02-07 1997-03-19 新技術事業団 両末端ヘテロ官能性ポリエーテル並びに該ポリエーテルを製造する方法及び重合開始剤
DK0627940T3 (da) 1992-03-05 2003-09-01 Univ Texas Anvendelse af immunokonjugater til diagnose og/eller terapi af vaskulariserede tumorer
US5395619A (en) 1993-03-03 1995-03-07 Liposome Technology, Inc. Lipid-polymer conjugates and liposomes
JP3465307B2 (ja) * 1993-08-05 2003-11-10 日本油脂株式会社 ポリアルキレンオキシド誘導体および製造方法
US6110491A (en) 1996-10-22 2000-08-29 Hermes Biosciences, Inc. Compound-loaded liposomes and methods for their preparation
WO1999029759A1 (en) * 1997-12-12 1999-06-17 Macromed, Inc. Heterofunctionalized star-shaped poly(ethylene glycols) for protein modification
US7244826B1 (en) 1998-04-24 2007-07-17 The Regents Of The University Of California Internalizing ERB2 antibodies
CA2346879A1 (en) 1998-09-16 2000-04-27 Alza Corporation Liposome-entrapped topoisomerase inhibitors
EP1141083B1 (de) * 1998-12-22 2004-08-18 Bayer MaterialScience AG Verfahren zur herstellung von hochverzweigten polyolen auf der basis von glycidol
US6822068B2 (en) * 1998-12-22 2004-11-23 Bayer Aktiengesellschaft Method for producing highly-branched glycidol-based polyols
US7009033B2 (en) 2001-07-02 2006-03-07 Polymer Source Inc. Heterofunctional polyethylene glycol and polyethylene oxide, process for their manufacture

Also Published As

Publication number Publication date
US7196145B2 (en) 2007-03-27
EP1663171A2 (de) 2006-06-07
DE602004019546D1 (de) 2009-04-02
WO2005037911A2 (en) 2005-04-28
EP1663171B9 (de) 2009-08-19
JP2007503514A (ja) 2007-02-22
ES2321841T3 (es) 2009-06-12
EP1663171B1 (de) 2009-02-18
US20050048650A1 (en) 2005-03-03
EP1663171A4 (de) 2006-10-18
WO2005037911A3 (en) 2006-03-30

Similar Documents

Publication Publication Date Title
ATE422880T1 (de) Heterofunktionelle copolymere von glycerol und polyethylenglykol, ihre konjugate und zusammensetzungen
ATE350409T1 (de) Ampholytisches copolymer und dessen verwendung
PH12019501613A1 (en) Site-directed modification of fviii
CY1110602T1 (el) Φαρμακευτικες συνθεσεις υπο μορφη γελης ή διαλυματος με βαση τη διυδροτεστοστερονη, μεθοδοι παρασκευης και χρησεις τους
DE502004010014D1 (de) Anionische ampholytische copolymere
DK1117440T3 (da) Farmaceutiske sammensætninger indeholdende paclitaxel
DE602005009175D1 (de) Gelzusammensetzung mit geladenen polymeren
DE602005026117D1 (de) Komprimierte pharmazeutische zusammensetzungen mit peg und elektrolyten
EA201390600A1 (ru) Терапевтические наночастицы с сополимерами с большим молекулярным весом
BRPI0518057A (pt) composições oftálmicas compreendendo polìmeros substituìdos com poliéter
AR041114A1 (es) Particulas polimericas que tienen grupos pendientes seleccionados y composicion preparada a partir de las mismas
FR2894585B1 (fr) Copolymere comprenant des unites zwitterioniques et d'autres unites, composition comprenant le copolymere, et utilisation
TR201909741T4 (tr) Kolon temizleme bileşimleri.
TR200103575T2 (tr) Sülfonamid ve sülfamid ikameli/katkılı imidazokinolinler
DE602004017252D1 (de) Körperlichepflegemittel Zusammensetzungen enthaltend strukturierte Pflegemittel-Vormischung
DE60326774D1 (de) Konjugate von cyanovirin-varianten und einem polyalkylenoxid
NO20032211D0 (no) Pulverbelegg med lav glans
DE60326150D1 (de) Anisinsäure und Glyceride enthaltende Zusammensetzungen
BR0209440A (pt) Sulfonamidas
EA200601596A1 (ru) Улучшенный состав 6-меркаптопурина
EA200300838A1 (ru) Композиция стабилизаторов для галогенированных полимеров, ее применение и полимеры, содержащие такие композиции
BR0008933A (pt) Composição para vela
BRPI0506631A (pt) combinações de um agente antiemético, composição farmacêutica e usos das combinações
CY1109541T1 (el) Φαρμακευτικη συνταγοποιηση για την θεραπεια οστεοαρθριτιδας η οποια περιεχει κλοδρονικο οξυ και υαλουρονικο οξυ
DE60209795D1 (de) Zusammensetzungen enthaltend endgruppen-verkappte polyalkylenglykole

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties